417 related articles for article (PubMed ID: 20849409)
1. The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden.
Davidson T; Ekermo B; Gaines H; Lesko B; Åkerlind B
Transfusion; 2011 Feb; 51(2):421-9. PubMed ID: 20849409
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe.
Mafirakureva N; Mapako T; Khoza S; Emmanuel JC; Marowa L; Mvere D; Postma MJ; van Hulst M
Transfusion; 2016 Dec; 56(12):3101-3111. PubMed ID: 27696441
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
[TBL] [Abstract][Full Text] [Related]
4. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
Japanese Red Cross NAT Screening Research Group
Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
[TBL] [Abstract][Full Text] [Related]
5. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
[TBL] [Abstract][Full Text] [Related]
6. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
7. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.
Yang MH; Li L; Hung YS; Hung CS; Allain JP; Lin KS; Tsai SJ
Transfusion; 2010 Jan; 50(1):65-74. PubMed ID: 19709394
[TBL] [Abstract][Full Text] [Related]
9. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
[TBL] [Abstract][Full Text] [Related]
11. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
12. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
Nübling CM; Unkelbach U; Chudy M; Seitz R
Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
[TBL] [Abstract][Full Text] [Related]
13. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.
Makroo RN; Choudhury N; Jagannathan L; Parihar-Malhotra M; Raina V; Chaudhary RK; Marwaha N; Bhatia NK; Ganguly AK
Indian J Med Res; 2008 Feb; 127(2):140-7. PubMed ID: 18403791
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing.
Murokawa H; Yoshikawa A; Ohnuma H; Iwata A; Katoh N; Miyamoto M; Mine H; Emura H; Tadokoro K;
Vox Sang; 2005 Jan; 88(1):10-6. PubMed ID: 15663717
[TBL] [Abstract][Full Text] [Related]
16. [Detection of the nucleic acids of hepatitis B and C viruses and human immunodeficiency virus for the biological screening of blood donations. Viral Hepatitis and Retrovirus Working Groups and Subgroup for Molecular Biology Applied to Transfusion Virology of the French Blood Transfusion Society].
Laperche S
Transfus Clin Biol; 1998 Apr; 5(2):139-46. PubMed ID: 9618839
[TBL] [Abstract][Full Text] [Related]
17. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
Seed CR; Kiely P; Keller AJ
Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands.
Borkent-Raven BA; Janssen MP; van der Poel CL; de Wit GA; Bonsel GJ; van Hout BA
Transfusion; 2009 Feb; 49(2):311-9. PubMed ID: 19389213
[TBL] [Abstract][Full Text] [Related]
19. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
[TBL] [Abstract][Full Text] [Related]
20. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
